We obtained CCA its mutation spectrum and frequently mutated genes, e.g., BCOR, FAT3, APC, and identified 118 novel pathogenic or likely pathogenic somatic mutations, which provided potential targets for early diagnosis and treatment planning of CCA. The gene discussed is FAT3; the disease is cholangiocarcinoma.